首页> 外文会议>Conference on lasers in surgery: Advanced characterization, therapeutics, and systems XI >In Vivo Tissue Repair Using Light-Activated Surgical Adhesive in a Porcine Model
【24h】

In Vivo Tissue Repair Using Light-Activated Surgical Adhesive in a Porcine Model

机译:在猪模型中使用光激活手术粘合剂的体内组织修复。

获取原文

摘要

An in vivo study was conducted to investigate the feasibility, mechanical function, and chronic biocompatibility of a new light-activated surgical adhesive for achieving rapid hemostasis of the puncture site following diagnostic catheterization and interventional cardiac procedures. Porcine carotid parteries (n=6) and femoral arteries (n=6) were exposed, and an incision was made in the arterial walls using a 16G needle. The surgical adhesive, composed of a poly(L-lactic-co-glycolic acid) scaffold doped with the traditional protein solder mix of serum albumin and indocyanine green dye, was used to close the incisions in conjunction with an 805nm diode laser. Blood flow was restored to the vessels immediatel after the procedure and the incision sites were checked for patency. The strength and hemostatic abilities of the new surgical adhesive were evaluated in the context of arterial pressure, persistence of hemostasis and presence of any inflammatory reaction after 3 days. After this evaluation period, the surgical procedure was repeated on the carotid arteries (n=6) and femoral arteries (n=6) of three additional animals that had been heparinized prior to surgery to closer approximate the conditions seen in a typical vascular surgical setting. The patency rate of both the unheparinized and heparinized vessels was 100percent at 3 days post-operative with envidence of intraluminal thrombosis seen in only one of the repaired vessels. The adhesive technique also compared favorably with a previous study conducted using conventional suture techniques. Repairs formed with the adhesive technique were achieved more rapidly than suturing, and acute leakage was observed less frequently. The new light-activated surgical adhesive thus has great promise as an alternative to conventional repair techniques for achieving rapid vascular hemostasis following cardiac procedures.
机译:进行了一项体内研究,以研究一种新型光活化外科手术粘合剂的可行性,机械功能和慢性生物相容性,以在诊断性导管插入术和介入性心脏手术后实现穿刺部位的快速止血。暴露猪的颈动脉(n = 6)和股动脉(n = 6),并使用16G针在动脉壁上切开一个切口。手术粘合剂由掺有血清白蛋白和吲哚菁绿色染料的传统蛋白质焊料混合物的聚(L-乳酸-乙醇酸共聚物)支架组成,并与805nm二极管激光器一起用于闭合切口。手术后立即恢复血管血流,并检查切口部位是否通畅。在3天后,根据动脉压,止血的持续性和是否存在任何炎症反应,评估了这种新型手术粘合剂的强度和止血能力。在此评估期之后,对另外三只在手术前已进行肝素化的动物的颈动脉(n = 6)和股动脉(n = 6)重复手术程序,以更接近典型血管外科手术中所见的情况。术后3天未肝素化和肝素化血管的通畅率均为100%,仅在其中一个修复的血管中可见腔内血栓形成。粘合技术也与使用传统缝合技术进行的先前研究相比具有优势。用胶粘剂技术形成的修复比缝合要快得多,而且很少见到严重渗漏。因此,这种新型的光活化外科手术粘合剂有望作为常规修复技术的替代品,以在心脏手术后实现快速的血管止血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号